Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Int J Cancer. 2013 May 9;133(9):2225–2233. doi: 10.1002/ijc.28202

Figure 2.

Figure 2

Combinatorial effect of MSA and MDV3100 on AR transactivation in 22Rv1 cells. (a) Cells transfected with ARE-luciferase construct were treated for 3 hr with 2 μM MSA and/or 5 μM MDV3100 in the absence of DHT, or with 2 μM MSA and/or 1 μM MDV3100 in the presence of 1 nM DHT. (b and c) Cells were treated for 6 hr with 10 μM MDV3100 and/or 4 μM MSA in the absence or presence of 1 nM DHT. *p < 0.05 from vehicle control or DHT control. **p < 0.05 from the MDV3100 group.